SCHEMBL14497005

SCHEMBL14497005

CSCC[C@H](CNC(=O)C(=O)Nc1ccc(Cl)cn1)NC(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPA1 O75762 1/20 0.43
▸ TSHR P16473 3/20 0.40
▸ L3MBTL1 Q9Y468 4/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ SYK P43405 1/20 0.39
▸ PTK2 Q05397 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.38
▸ CTSS P25774 1/20 0.38
▸ CTSK P43235 1/20 0.38
▸ CA2 P00918 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ NPC1 O15118 4/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14497000 0.91 TRPA1 (0.45) TRPA1TSHRL3MBTL1MAPK1SYK
SCHEMBL14496990 0.87 SYK (0.51) TRPA1TSHRL3MBTL1MAPK1SYK
SCHEMBL5542886 0.86 L3MBTL1 (0.44) TSHRL3MBTL1MAPK1PTK2TDP1
SCHEMBL14497008 0.86 TRPA1 (0.42) TRPA1TSHRL3MBTL1MAPK1SYK
SCHEMBL14497038 0.85 TRPA1 (0.44) TRPA1TSHRL3MBTL1MAPK1SYK
SCHEMBL14497002 0.84 TRPA1 (0.44) TRPA1TSHRL3MBTL1MAPK1SYK
SCHEMBL14496988 0.83 TRPA1 (0.51) TRPA1TSHRL3MBTL1MAPK1PTK2
SCHEMBL14496962 0.83 TRPA1 (0.51) TRPA1TSHRL3MBTL1MAPK1PTK2
SCHEMBL14497011 0.82 TRPA1 (0.42) TRPA1TSHRL3MBTL1MAPK1SYK
SCHEMBL14497054 0.81 TRPA1 (0.47) TRPA1TSHRL3MBTL1MAPK1PTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070129371-A1 Novel ethylenediamine derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-06-07 — — US disclosed
US-20070129371-A1 Novel ethylenediamine derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-06-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070129371-A1 Novel ethylenediamine derivatives C1R, C9, C1S TRPA1 1764/4885TSHR 126/4885L3MBTL1 91/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback